What’s Next for La Jolla Pharmaceutical (LJPC) Stock?


La Jolla Pharmaceutical Company (LJPC) stock down -4.8% Wednesday and higher by 81.6% over the past week. LJPC stock is lower by -68.53% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives LJPC stock a score of 71 out of a possible 100.

That score is mainly influenced by a long-term technical score of 82. LJPC’s score also includes a fundamental score of 78. In addition to the average rating from Wall Street analysts, LJPC stock has a mean target price of $19.50. This means analysts expect the stock to add 101.86% over the next 12 months. The short-term technical score for LJPC is 54.

Click Here to get the full Stock Score Report on La Jolla Pharmaceutical Company (LJPC).

What’s Happening with LJPC Stock Today

La Jolla Pharmaceutical Company (LJPC) stock is lower by -4.83% while the S&P 500 is lower by -0.16% as of 3:22 PM on Wednesday, Jun 12. LJPC is lower by -$0.49 from the previous closing price of $10.15 on volume of 1,267,968 shares. Over the past year the S&P 500 is higher by 3.56% while LJPC is lower by -68.53%. LJPC lost -$6.84 per share in the over the last 12 months.

Symbols: LJPC

You May Also Like